[Possibilities of boron neutron capture therapy in the treatment of malignant brain tumors].
Vestn Rentgenol Radiol
; (6): 36-42, 2015.
Article
em Ru
| MEDLINE
| ID: mdl-26999933
ABSTRACT
Boron neutron capture therapy (BNCT) that is of the highest attractiveness due to its selective action directly on malignant tumor cells is a promising approach to treating cancers. Clinical interest in BNCT focuses in neuro-oncology on therapy for gliomas, glioblastoma in particular, and BNCT may be used in brain metastatic involvement. This needs an epithermal neutron source that complies with the requirements for BNCT, as well as a 10B-containing agent that will selectively accumulate in tumor tissue. The introduction of BNCT into clinical practice to treat patients with glial tumors will be able to enhance therapeutic efficiency.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Encefálicas
/
Compostos de Boro
/
Terapia por Captura de Nêutron de Boro
Limite:
Humans
Idioma:
Ru
Revista:
Vestn Rentgenol Radiol
Ano de publicação:
2015
Tipo de documento:
Article